Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duopa Continuation in Advanced Parkinson's Disease
NCT00660673Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Nov 2009
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of levodopa in Parkinson's disease (PD), sponsored by AbbVie Inc.. Started Nov 2009; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00660673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660673.